We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
(Approval lapsed) FluQuadri Quadrivalent Influenza Vaccine, Types A and B subvirion, 0.5mL suspension for injection 2022 (International Presentation)
Section 19A approved medicine
(Approval lapsed) FluQuadri Quadrivalent Influenza Vaccine, Types A and B subvirion, 0.5mL suspension for injection 2022 (International Presentation)
Section 19A approval holder
Sanofi-Aventis Australia Pty Ltd ABN 31 008 558 807
Phone
1800 818 806
Approved until
Status
Expired
Medicines in short supply/unavailable
FluQuadri Inactivated Quadrivalent Influenza Vaccine (Split Virion), Influenza virus haemagglutinin 60mcg, 0.5mL suspension for injection 2022 - ARTG 213963
Indication(s)
FluQuadri is indicated for active immunisation of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.
FluQuadri is indicated for use in adults and children 6 months and older.
Images
